Literature DB >> 12072331

Is lamivudine with 1-week HBlg as effective as long-term high-dose HBlg in HBV prophylaxis after liver transplantation?

S-J Park1, S W Paik, M S Choi, J H Lee, K C Koh, S J Kim, J W Joh, S K Lee.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 12072331     DOI： 10.1016/s0041-1345(02)02637-4

Source DB:  PubMed          Journal:  Transplant Proc        ISSN： 0041-1345            Impact factor:   1.066


× No keyword cloud information.
  5 in total

Review 1.  Recent advances in prevention of hepatitis B recurrence after liver transplantation.

Authors:  Zhi-Feng Xi; Qiang Xia
Journal:  World J Gastroenterol       Date:  2015-01-21       Impact factor: 5.742

Review 2.  Management of hepatitis B virus infection after liver transplantation.

Authors:  Miguel Jiménez-Pérez; Rocío González-Grande; José Mostazo Torres; Carolina González Arjona; Francisco Javier Rando-Muñoz
Journal:  World J Gastroenterol       Date:  2015-11-14       Impact factor: 5.742

3.  Network meta-analysis on prophylactic regimens against recurrent hepatitis B virus infection after liver transplantation.

Authors:  Yaxiong Zhang; Shiyang Kang; Wenfeng Fang; Xuan Wu; Wenhua Liang
Journal:  Hepatobiliary Surg Nutr       Date:  2013-12       Impact factor: 7.293

Review 4.  Prevention and Treatment of Recurrent Hepatitis B after Liver Transplantation.

Authors:  Rakhi Maiwall; Manoj Kumar
Journal:  J Clin Transl Hepatol       Date:  2016-03-15

Review 5.  Immunoglobulin, nucleos(t)ide analogues and hepatitis B virus recurrence after liver transplant: A meta-analysis.

Authors:  Quirino Lai; Gianluca Mennini; Francesco Giovanardi; Massimo Rossi; Edoardo G Giannini
Journal:  Eur J Clin Invest       Date:  2021-05-03       Impact factor: 4.686
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.